Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M43,074Revenue $M5,770Net Margin (%)6.3Z-Score1.4
Enterprise Value $M59,978EPS $-2.7Operating Margin %20.2F-Score3
P/E(ttm))0Cash Flow Per Share $4.9Pre-tax Margin (%)5.4Higher ROA y-yN
Price/Book8.610-y EBITDA Growth Rate %2.9Quick Ratio1.7Cash flow > EarningsY
Price/Sales5.85-y EBITDA Growth Rate %42.8Current Ratio2.1Lower Leverage y-yN
Price/Cash Flow11.8y-y EBITDA Growth Rate %57.2ROA % (ttm)2.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)11.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M334ROI % (ttm)-4.0Gross Margin Increase y-yN

Gurus Latest Trades with VRX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXGlenn Greenberg 2014-06-30 Add2.33%$116.99 - $138.13
($127.6)
$ 129.131%Add 8.19%6,050,442
VRXAndreas Halvorsen 2014-06-30 Add1.39%$116.99 - $138.13
($127.6)
$ 129.131%Add 27.27%11,830,932
VRXSteve Mandel 2014-06-30 Add0.64%$116.99 - $138.13
($127.6)
$ 129.131%Add 14.44%10,089,450
VRXLee Ainslie 2014-06-30 Add0.37%$116.99 - $138.13
($127.6)
$ 129.131%Add 8.39%2,625,014
VRXGeorge Soros 2014-06-30 Add0.29%$116.99 - $138.13
($127.6)
$ 129.131%Add 185.46%472,187
VRXChris Davis 2014-06-30 Add0.17%$116.99 - $138.13
($127.6)
$ 129.131%Add 16.03%3,153,748
VRXJoel Greenblatt 2014-06-30 Buy 0.01%$116.99 - $138.13
($127.6)
$ 129.131%New holding, 6172 sh.6,172
VRXDaniel Loeb 2014-06-30 Sold Out -0.48%$116.99 - $138.13
($127.6)
$ 129.131%Sold Out0
VRXJohn Paulson 2014-06-30 Reduce-0.32%$116.99 - $138.13
($127.6)
$ 129.131%Reduce -49.97%500,300
VRXWallace Weitz 2014-06-30 Reduce-0.19%$116.99 - $138.13
($127.6)
$ 129.131%Reduce -2.91%1,551,076
VRXMariko Gordon 2014-06-30 Sold Out -0.13%$116.99 - $138.13
($127.6)
$ 129.131%Sold Out0
VRXLee Ainslie 2014-03-31 Add1.46%$112.62 - $148
($136.19)
$ 129.13-5%Add 48.23%2,421,778
VRXChris Davis 2014-03-31 Add0.95%$112.62 - $148
($136.19)
$ 129.13-5%Add 2686.89%2,718,162
VRXJohn Paulson 2014-03-31 Buy 0.65%$112.62 - $148
($136.19)
$ 129.13-5%New holding, 1000000 sh.1,000,000
VRXSteve Mandel 2014-03-31 Add0.61%$112.62 - $148
($136.19)
$ 129.13-5%Add 13.67%8,816,702
VRXAndreas Halvorsen 2014-03-31 Add0.53%$112.62 - $148
($136.19)
$ 129.13-5%Add 11.61%9,296,143
VRXDaniel Loeb 2014-03-31 Buy 0.48%$112.62 - $148
($136.19)
$ 129.13-5%New holding, 250000 sh.250,000
VRXGeorge Soros 2014-03-31 Buy 0.22%$112.62 - $148
($136.19)
$ 129.13-5%New holding, 165411 sh.165,411
VRXGlenn Greenberg 2014-03-31 Reduce-2.5%$112.62 - $148
($136.19)
$ 129.13-5%Reduce -8.52%5,592,558
VRXWallace Weitz 2014-03-31 Reduce-0.99%$112.62 - $148
($136.19)
$ 129.13-5%Reduce -13.61%1,597,540
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRX Joel Greenblatt 2014-06-306,17200.01New Buy
VRX George Soros 2014-06-30472,1870.140.45+185.46%
VRX Andreas Halvorsen 2014-06-3011,830,9323.556.5+27.27%
VRX Chris Davis 2014-06-303,153,7480.951.2+16.03%
VRX Steve Mandel 2014-06-3010,089,4503.025.1+14.44%
VRX Jean-Marie Eveillard 2014-06-301,024,4020.310.31+13.5%
VRX Lee Ainslie 2014-06-302,625,0140.794.8+8.39%
VRX Glenn Greenberg 2014-06-306,050,4421.8130.8+8.19%
VRX Ruane Cunniff 2014-06-3034,298,38410.2823.1+0.24%
VRX Lou Simpson 2014-06-301,615,5490.488.2+0.06%
VRX Jeff Ubben 2014-06-3018,923,8775.6717.6
VRX Private Capital 2014-06-30300,4460.094.3-1.02%
VRX Wallace Weitz 2014-06-301,551,0760.465.9-2.91%
VRX John Paulson 2014-06-30500,3000.150.27-49.97%
VRX Daniel Loeb 2014-06-30000Sold Out
VRX Mariko Gordon 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-06-23Sell10,203$121.75.81view
Mirovsky PavelPresident of Valeant Europe 2014-06-02Sell10,000$131.25-1.89view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-05-13Sell10,000$130.08-1.01view
Provencio Norma AnnDirector 2014-04-01Sell5,000$132.18-2.58view
Kornwasser LaizerEVP, Company Group Chairman 2014-03-21Buy2,481$134.97-4.59view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-03-17Sell5,000$141.72-9.14view
Provencio Norma AnnDirector 2014-03-03Sell5,000$141.62-9.07view
Provencio Norma AnnDirector 2014-02-03Sell5,000$136.23-5.48view
Kornwasser LaizerEVP, Company Group Chairman 2014-01-24Buy2,536$132.15-2.56view
Provencio Norma AnnDirector 2014-01-13Sell5,000$133-3.18view

Press Releases about VRX :

    Quarterly/Annual Reports about VRX:

    News about VRX:

    Articles On GuruFocus.com
    Wallace Weitz's Partners Value Fund Q3 2014 Commentary Oct 16 2014 
    Ackman's Pershing Square Now Available To The Public Oct 13 2014 
    Bill Ackman and Valeant Could Sweeten Allergan Deal By $15 A Share Oct 10 2014 
    Wallace Weitz's Value Fund Q2 Commentary Oct 06 2014 
    Transcript of Ruane, Cunniff & Goldfarb Investor Day - May 16, 2014 Oct 05 2014 
    Most Held Canadian Stocks of the Second Quarter Sep 04 2014 
    Valeant Pharmaceuticals Part XII: the rolling solvency calculation Sep 02 2014 
    Valeant Pharmaceuticals part XI: Less luscious lips Aug 13 2014 
    Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables Aug 11 2014 
    Diamond Hill Capital Comments on Valeant Pharmaceuticals International Inc Jul 25 2014 

    More From Our Partners
    Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker Oct 20 2014 - BENZINGA

    More From Other Websites
    Valeant (VRX) Beats Earnings Estimates in Q3, Shares Gain Oct 23 2014
    Allergan keeps a few secrets, court filing shows Oct 21 2014
    Meister wants Allergan to sell for highest price Oct 21 2014
    Will This Price Target Increase Help Valeant Pharmaceuticals (VRX) Stock Today? Oct 21 2014
    Valeant hints at higher bid for Allergan Oct 20 2014
    Can Valeant's Strong Q3 Entice Allergan? Oct 20 2014
    After Tax Inversion Rules Change, AbbVie and Shire Agree to Terminate Their Deal Oct 20 2014
    VALEANT PHARMACEUTICALS INTL (VRX) Earnings Report: Q3 2014 Conference Call Transcript Oct 20 2014
    Allergan files rebuttal to Valeant earnings Oct 20 2014
    Paulson & Co. pushes for Allergan merger with Shire: report Oct 20 2014
    IBM weighs heavily on the Dow Oct 20 2014
    [video] Report: Paulson pushing Allergan-Shire merger Oct 20 2014
    Jim Cramer: Valeant Pharmaceuticals and Allergan Are Winners Oct 20 2014
    [$$] Valeant Pushes Business Strength Oct 20 2014
    [video]Stock Market Today: Dow Falls, Broader Market Rises as IBM Cuts Outlook Oct 20 2014
    Strong On High Volume: Valeant Pharmaceuticals International (VRX) Oct 20 2014
    [video] Cramer's Stop Trading: Valeant & Allergan Oct 20 2014
    Stocks to Watch: IBM, NCR, Halliburton Oct 20 2014
    Morning Movers: IBM Sinks Dow Industrial Average; Halliburton Jumps on Earnings Beat Oct 20 2014
    Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results (pdf version) Oct 20 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK